Sandip Kapadia, CHIEF FINANCIAL OFFICER at Harmony Biosciences Holdings, Inc. (HRMY), sold 5,587 shares at $38.05 ($213K) on 2025-01-27, disclosed to the SEC on 2025-01-28.
Scheduled sale ($213k) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.01 | 2,037 | $77K | 36.4% |
| 2 | $38.05 | 1,775 | $68K | 31.8% |
| 3 | $38.05 | 1,775 | $68K | 31.8% |
| Total | $38.04 avg | 5,587 | $213K | 100% |
| Filing → |
| HRMY | SELL | 2025-12-09 | $791K | — | Filing → |
| HRMY | SELL | 2025-11-25 | $120K | — | Filing → |
| HRMY | SELL | 2025-08-19 | $1.6M | — | Filing → |